Registration for GMAT™ Focus Edition to Open in August 2023

Free prep materials available two months prior to propel candidates to success on their business school journey

RESTON, Va., May 02, 2023 (GLOBE NEWSWIRE) — The Graduate Management Admission Council™ (GMAC), a global association representing leading business schools, today announced that registration for the GMAT™ Focus Edition, an updated version of the Graduate Management Admission Test™ (GMAT™) exam, will open on August 29, 2023 for testing in the fourth quarter this year. In addition, official GMAT Focus prep materials will be available on on June 6, 2023, with a free study planner of only six weeks to help test takers stick to a schedule, inform prep activities, and track progress, as well as a free GMAT Focus Official Starter Kit that comes with a sampler of 70 real GMAT questions and two full-length practice exams to help candidates establish performance baseline.

Earlier this year, GMAC introduced GMAT Focus Edition after extensive research efforts involving hundreds of school professionals and an in-depth concept testing with thousands of students globally. The GMAT, the most widely used business school admissions exam in the past seven decades, was redesigned with improved test taking experience and flexible new features to better support candidates of graduate business education. Schools will benefit from it as an improved element in their holistic admissions process.

“We want to encourage people with a broad set of qualifications, undergraduate backgrounds and lived experiences to understand the richness of their choice and take that leap forward on their business school journey,” said Joy Jones, CEO of GMAC. “It is our belief that GMAT Focus Edition will allow candidates to optimize their preparation for graduate business education while helping schools attract a global pool of qualified and diverse applicants.”

“This is an important evolution of the test,” said Bruce DelMonico, Assistant Dean for Admissions at Yale School of Management and a board member of GMAC. “In terms of the relevance and usefulness of the test, this is definitely a positive step that will be beneficial both to business schools and to candidates.”

More efficient, more flexible, and more insightful, in an all-new testing experience

The GMAT Focus Edition will feature three 45-minute sections: Quantitative Reasoning, which examines problem solving skills; Verbal Reasoning, which evaluates critical reasoning and reading comprehension but no longer incorporates sentence correction; and the newly developed Data Insights section, which measures candidates’ data literacy skills and ability to analyze and interpret data and apply it to real-world business scenarios. With these changes and the removal of the Analytical Writing Assessment (AWA), it is nearly one hour shorter than the current version of the GMAT and therefore requires less content to prepare. Besides new features that allow test takers to bookmark as many questions as they want, review questions within the remaining section time and change up to three answers per section, and to complete the three sections in any order, the enhanced Official Score Report now offers detailed performance insights that helps them assess strengths and identify focus areas at no additional cost.

“I think the redesign of the GMAT exam is testament to GMAC’s commitment to continuous improvement. Changes to the exam address the growing importance of certain competencies and the future of work – for example with the addition of Data Insight,” said Arnold Longboy, Executive Director, Recruitment & Admissions at London Business School.

New score scale and concordance to help assess candidate competitiveness

The GMAT Focus Edition’s Total Score, ranging from 205 to 805, is based on test taker performance on all three sections of the exam, with each section, ranging from 60 to 90, weighted equally. This change has been made to ensure that test takers and schools can easily distinguish from a GMAT Focus Edition score to the currently available GMAT Exam score, which ranges from 200 to 800. To understand a test taker’s relative competitiveness, one can use the concordance tables available on that link score distributions between the two versions of the exam by percentile. With the GMAT Focus Edition’s new score scale, percentile rankings deserve the primary attention from test takers and schools when looking to understand the results.

“When comparing scores of GMAT Focus Edition to the current version of the GMAT Exam, we encourage test takers and schools to compare percentile rankings rather than comparing total scores,” stressed Manish Dharia, director of product development at GMAC. “Because the Total Score scale and the score scale distribution have both changed, comparing total scores or section scores from the current version of the exam to the GMAT Focus Edition is not appropriate, accurate, or a meaningful comparison of performance. Scores of 600 and 605 may look similar, but they represent very different performance levels on different skills.”

Additional efforts to facilitate smooth transition and swift adoption

As GMAT Focus Edition rolls out for the remainder of 2023, the current version of the GMAT exam will continue to be available to candidates until early next year to facilitate their in-progress preparation and applications for business school. Also, to that end, the GMAT Focus Edition fees will remain the same as the current GMAT exam.

“Keep in mind, all GMAT exam scores – whether they are of the current GMAT or GMAT Focus Edition – continue to be valid for 5 years,” said Ashish Bhardwaj, senior vice president and head of market development at GMAC. “With the advance announcement of the new edition, we encourage candidates to proceed with registering and taking the GMAT exam in ways that best enable their pursuit of graduate management education.”

About GMAC

The Graduate Management Admission Council (GMAC) is a mission-driven association of leading graduate business schools worldwide. GMAC provides world-class research, industry conferences, recruiting tools, and assessments for the graduate management education industry as well as resources, events, and services that help guide candidates through their higher education journey. Owned and administered by GMAC, the Graduate Management Admission Test™ (GMAT™) exam is the most widely used graduate business school assessment.

More than 12 million prospective students a year trust GMAC’s websites, including, to learn about MBA and business master’s programs, connect with schools around the world, prepare and register for exams and get advice on successfully applying to MBA and business master’s programs. BusinessBecause and GMAC Tours are subsidiaries of GMAC, a global organization with offices in China, India, the United Kingdom, and the United States.

To learn more about our work, please visit

Media Contact:

Teresa Hsu
Sr. Manager, Media Relations
Mobile: 202-390-4180

GlobeNewswire Distribution ID 8829077

Amii welcomes over 2000 of the world’s brightest minds in AI to annual Upper Bound event

Four days of events include keynotes, panels, demos and socials from world-leading AI researchers and innovative business leaders

EDMONTON, Alberta, May 02, 2023 (GLOBE NEWSWIRE) — Amii (Alberta Machine Intelligence Institute) welcomes the world AI community to Edmonton, Alberta, Canada for Upper Bound, May 23-26. All are invited to attend the multi-day event, with diverse programming catered for AI researchers, industry leaders, pop culture enthusiasts and anyone who has ever been curious about artificial intelligence.

In-person and virtual tickets start at $0. Registration and schedules are available at 

A celebration of AI excellence in Alberta and beyond, Upper Bound will take over Edmonton with a full event schedule and more than 100 events taking place in the downtown core. Upper Bound is pleased to welcome our 2023 keynote speakers including:

  • Richard S. Sutton, trailblazing AI researcher and Amii Chief Scientific Advisor, considered by many as the pioneer of reinforcement learning | Ticket Access: Community Pass, Upper Bound Pass, Talent Bursary All Access and Online Pass 
  • Cam Linke, CEO, Amii | Ticket Access: Upper Bound Pass, Talent Bursary All Access and Online Pass
  • Peter Stone, Executive Director of Sony AI America | Ticket Access: Academic Symposium and Upper Bound Pass (limited)
  • Marlos Machado, Amii Fellow & Canada CIFAR AI Chair | Ticket Access: Academic Symposium 

“AI is the most important tool of our time, and it continues to dominate global conversation,” says Cam Linke, CEO of Amii. “Upper Bound puts a spotlight on Alberta’s AI leadership and legacy and is a celebration of AI that welcomes everybody to learn, network, discuss and join in on the conversation. This is an invitation for the world’s AI community to experience the best of what Amii and Canada has to offer in scientific excellence, start-up creation and industry application — so they can leave inspired by the connections they’ve made, the information learned, and their ambitious ideas realized.”

Upper Bound is an AI event for everyone and includes sessions, demos, networking events and socials open for a range of ages and familiarity with AI. Scheduled events include:

  • An Academic Symposium, showcasing leading research and organized by Amii Fellows from the University of Alberta, one of the world’s top academic institutions for AI research.
  • Panels on AI in industry, including discussions on innovative applications of AI in industry; the demand for AI talent; advancing cellular agriculture; ventures and start-ups; and more.
  • AI & Culture, high-energy and fun events for all AI enthusiasts.
  • Social and networking opportunities with daily coffee catch up, beers with peers and the hottest ticket in town, the official Upper Bound Party.

Last year more than 2,000 attendees from 38 countries attended the inaugural event. Amii awarded Talent Bursaries to over 500 recipients from around the world to cover travel and accommodation costs with over 69% of recipients self-identified as members of underrepresented groups in STEM.

This year, Amii has awarded over $500,000 in Talent Bursaries to support 700 recipients from 22 countries to Upper Bound in person. An additional 612 global Talent Bursary applicants received Online Pass access for live-streamed content and full immersion in the Upper Bound app.

Upper Bound is proudly presented by Amii. One of Canada’s three centres of AI excellence as part of the Pan-Canadian AI strategy, Amii is an Alberta-based, non-profit institute that supports world-leading research in artificial intelligence and machine learning and translates scientific advancement into industry adoption. Learn more at

Media Contact

Lynda Vang, Communications Specialist


GlobeNewswire Distribution ID 8829558

Student Researchers Use UAE-Developed Generative AI Technology to Find New Brain Tumor Drug Targets

Abu Dhabi, May 02, 2023 (GLOBE NEWSWIRE) — Three high school students – Andrea Olsen from Oslo, Norway; Zachary Harpaz from Boca Raton, Florida; and Chris Ren from Shanghai, China – co-authored a paper using a generative artificial intelligence (AI) engine for target discovery from Insilico Medicine (“Insilico”) called PandaOmics to identify new therapeutic targets for glioblastoma multiforme (GBM). GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors. The findings were published on April 26 in the journal Aging.

Much of the technology behind PandaOmics is being developed in Insilico’s Generative Artificial Intelligence and Quantum Computing Research and Development Center in Abu Dhabi, the region’s largest AI-powered biotechnology research center.

Olsen, a student at Sevenoaks School in Kent, UK, began interning at Insilico Medicine in 2021, after discovering her interest in neurobiology and technology. For the current paper, the fifth scientific paper she has co-authored before turning eighteen, she and other researchers used PandaOmics to screen datasets from the Gene Expression Omnibus repository maintained by the National Center for Biotechnology Information and found new therapeutic targets implicated for treating both aging and glioblastoma multiforme.

Ren, a student at Shanghai High School International Division, has an interest in biology and biomarkers and joined them in the summer of 2022.

While there would seem to be a clear connection between aging and cancer, Olsen says their findings were more nuanced. “Sometimes, instead of aging, the body switches to cancer mechanisms, which was really interesting to discover.” She hypothesized that “the body is trying to preserve itself in a way that it is switching back to embryonic processes of cell division.” GBM is caused by a genetic mutation that leads to uncontrolled growth of glial cells, or cells that surround neurons in the brain. Even with existing therapies, the median survival for GBM patients is only 15 months.

Harpaz, a student at Pine Crest School in Ft. Lauderdale, had an early interest in computer science and AI and soon developed a passion for biology as well. “I wanted to combine my two favorite topics, computer science and biology, into what I think is the most interesting field of biology – aging research,” Harpaz says. He discovered generative AI drug discovery company Insilico Medicine whose founder and CEO, Alex Zhavoronkov, PhD, connected him with Olsen. The two young researchers began collaborating on the glioblastoma project and ultimately presented findings at the Aging Research and Drug Discovery (ARDD) conference in Copenhagen, where they together launched the Youth Longevity Association (TYLA).

In this latest paper, the three teens used PandaOmics to analyze the genes and identified three that were strongly correlated with both aging and glioblastoma and could serve as potential therapeutic targets for new drugs.

“We selected the genes that were overlapped to be highly correlated in 11 of the 12 datasets, and we split our data into young, middle aged, and senior groups,” said Harpaz. “We mapped this to the importance of the gene expression to survival.” After identifying two genetic targets for glioblastoma and aging – CNGA3 and GLUD1 – they cross-referenced their findings with earlier findings from Insilico around genes strongly correlated with aging and identified a third target – SIRT1.

“I learned a lot about conducting a research project,” said Ren, who helped review the three targets. “The PandaOmics platform really made the project accessible to me. As a high school sophomore, I did not have sufficient experience for advanced research and analysis, however, I was still able to navigate the PandaOmics platform after a brief period of training to process and compare datasets of glioblastoma.”

The students say they are eager to continue their studies in AI and biology into college and to move the GBM research forward from target discovery to drug development.

“The best way to take this research further is going to be using Insilico’s Chemistry42 software, where we can take the targets we identified through PandaOmics and generate small molecules, potential drugs, with these targets that have the potential to treat glioblastoma and aging at the same time,” says Harpaz.

Prior to her internship at Insilico, Olsen says: “I never knew that AI could be so helpful in finding completely new therapeutic targets. For me, that was an incredible opportunity to dive into the field of research, aging, longevity, and neuroscience. It really kick-started my entire career.”

“I am truly impressed by the commitment of these young researchers,” says Zhavoronkov. “I hope their work will inspire other young people excited about science and technology to look at how they can use AI tools to discover new targets and treatments for both aging and disease.”


About Insilico Medicine

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. In early 2023, the Company opened the Insilico Medicine Generative Artificial Intelligence and Quantum Computing Research and Development Centre in Abu Dhabi, the region’s largest AI-powered biotechnology research center. The R&D hub brings together global talent in artificial intelligence and software development to expand the capabilities of Insilico’s end-to-end AI-driven drug discovery platform, Pharma.AI, explore aging research and sustainable chemistry, and support the digital transformation of healthcare in the region.

For more information, visit


Jamila Alhammadi 
Insilico Medicine

GlobeNewswire Distribution ID 8829593

Bombardier Leads Industry-Wide Sustainability Efforts with Landmark Environmental Product Declarations for Global 5500 and Global 6500 Aircraft

Bombardier Environmental Product Declarations (EPDs)

Bombardier Leads Industry-Wide Sustainability Efforts with Landmark Environmental Product Declarations for Global 5500 and Global 6500 Aircraft

  • Environmental Product Declarations (EPDs) provide detailed information about each aircraft’s environmental footprint across its life cycle
  • Bombardier’s unique Product Sustainability and Strategy team analyzed environmental incidence of over 140K aircraft parts per program to create holistic and transparent public reports
  • Long-range Global 5500 and Global 6500 aircraft join Global 7500 and Challenger 3500 as world’s only business jets carrying an EPD
  • Global 5500 and Global 6500 EPDs contribute to Bombardier’s long-term view EcoJet research platform

MONTREAL, May 02, 2023 (GLOBE NEWSWIRE) — Bombardier today announced that it has completed a thorough analysis of the Global 5500 and Global 6500 in order to publish Environmental Product Declarations (EPDs) for two of its large aircraft. They join the Global 7500 aircraft and the Challenger 3500 aircraft as business aviation’s only EPD-designated jets.

For over a decade, Bombardier dedicated a full-time internal team of experts to the development of standardizable key metrics, data gathering, validation and analysis. Bringing together industry players and 45 tier-1 suppliers, Bombardier assessed 200K aircraft parts over the development of the Global 7500 aircraft program, gaining valuable insights on the environmental impact of this business jet and leading to a third-party verified public report.

The industry-leading, high-performance Global 7500 aircraft became the first business aircraft to receive an EPD designation for this report in 2020 and was followed by the Challenger 3500 EPD in 2022. The holistic methodology was replicated in analyzing the Global 5500 and Global 6500 programs, where 280K parts were assessed.

“The publication of the Global 5500 and Global 6500 aircraft EPDs are the results of years of scientific effort,” said Michel Ouellette, Executive Vice President, Engineering and Product Development, Bombardier. “These declarations are more than brochures: they are tools for the aviation industry to drive sustainable innovations across its activities spectrum. They are also the outcome of the thoroughness, mindfulness and ingenuity of a uniquely skilled internal team of experts. As a company, we are immeasurably proud that the reputation of our products and exciting opportunities attract the best minds in the world.”

Thanks to the colossal groundwork done by Bombardier’s dedicated team in establishing environmental requirements at the design phase of future programs, the Global 5500 and Global 6500 business jets possess strong sustainability elements. From a design perspective, they feature up to 13% better fuel efficiency than their predecessors with redesigned wings and new purpose-built Rolls-Royce Pearl engines. The high-speed transonic wing on these aircraft also cuts down on drag, reducing fuel burn, and lowering emissions, offering a smooth ride, excellent short-field and high-speed performance. Bombardier also currently offers sustainable cabin material options for the interior of all aircraft.

“Bombardier has the influence and expertise to change the future of aviation,” said Michel Ouellette, “We made the decision over 10 years ago to tackle the industry’s most urgent challenge in the long run with our EcoJet research platform; in the short run by encouraging the increased use of Sustainable Aviation Fuels (SAF); and in the medium run by adopting a sustainability mindset when designing all our aircraft; before the first piece of sheet metal is cut. With our business jets EPDs, we have equipped ourselves with a comprehensive and replicable methodology to ensure environmental risks and impacts across our value chain are identified now, and effectively managed through our continuous innovation and improvement approach.”

The extensive data gleaned in the development of Bombardier’s product life cycle analysis, which is available for the industry and the public to consult, help key players reevaluate how current aircraft are designed and built. Bombardier’s sustainable cabin interiors materials offering is one example of how this life cycle analysis led to tangible product improvement. Meanwhile, in working towards inventing the future of sustainable aviation with its long-term view EcoJet research platform, these EPDs are already influencing decisions at the supply chain level, by mapping a clear strategy for sustainable sourcing and product development processes.

Bombardier’s overall environmental, social and governance (ESG) plan also supports the industry-wide aspiration to achieve net zero emissions by 2050, by actively advocating for the adoption of Sustainable Aviation Fuels, enhancing aircraft recoverability and sustainable sourcing, improving energy efficiency in its operations, optimizing carbon offsets, and more.

About Bombardier

Bombardier (BBD-B.TO) is a global leader in aviation, focused on designing, manufacturing, and servicing the world’s most exceptional business jets. Bombardier’s Challenger and Global aircraft families are renowned for their cutting-edge innovation, cabin design, performance, and reliability. Bombardier has a worldwide fleet of approximately 5,000 aircraft in service with a wide variety of multinational corporations, charter and fractional ownership providers, governments, and private individuals. Bombardier aircraft are also trusted around the world in government and military special-mission roles leveraging Bombardier Defense’s proven expertise.

Headquartered in Greater Montréal, Québec, Bombardier operates aerostructure, assembly and completion facilities in Canada, the United States and Mexico. The company’s robust customer support network services the Learjet, Challenger and Global families of aircraft, and includes facilities in strategic locations in the United States and Canada, as well as in the United Kingdom, Germany, France, Switzerland, Italy, Austria, the UAE, Singapore, China and Australia.

For corporate news and information, including Bombardier’s Environmental, Social and Governance report, as well as the company’s plans to cover all its flight operations with Sustainable Aviation Fuel (SAF) utilizing the Book and Claim system visit Learn more about Bombardier’s industry-leading products and customer service network at Follow us on Twitter @Bombardier.

Bombardier, Challenger, Challenger 3500, Global, Global 5500, Global 6500 and Global 7500 are registered or unregistered trademarks of Bombardier Inc. or its subsidiaries.

For Information
Marie-Andrée Charron
+1 514-441-2598

A photo accompanying this announcement is available at

GlobeNewswire Distribution ID 8829771

Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023

Mont-Saint-Guibert, Belgium – May 1, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter of 2023 on Tuesday, May  16, 2023, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

Investors interested in listening to the conference call may do so by registering for a unique personal PIN at the following link: A live and archived webcast of the event will be available on the Company’s investor relations website at

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

David DeMartino, Chief Strategy Officer
+1 310 310 1313


GlobeNewswire Distribution ID 1000807406

Ghani Global Glass Limited Appoints New Directors to Fill Casual Vacancies

Karachi, The Board of Directors of Ghani Global Glass Limited announced the appointment of three new directors to fill casual vacancies on the board. The appointments were made during a board meeting where Ms. Ayesha Masroor, Mr. Ubaid Waqar, and Mr. Muhammad Danish Siddique tendered their resignations as Non-Executive and Independent Directors due to personal reasons.

To replace Ms. Masroor, the board appointed Mr. Abdullah Ahmad as the new Non-Executive Director with immediate effect. To fill the vacancy left by Mr. Waqar, the board appointed Mr. Mahmood Ahmed as the new Independent Director. The board appointed Ms. Farzin Khan as the new Independent Director in place of Mr. Siddique.

United Bank Limited appoints new President and CEO

Karachi, United Bank Limited (UBL) has announced the appointment of Mr. Muhammad Jawaid Iqbal as the new President and CEO, effective from 02 May 2023. Mr. Iqbal is taking over the reins of UBL from Mr. Shahzad G. Dada, who has proceeded on leave for personal reasons until the expiry of his three-year term on 30 June 2023.

Commenting on his appointment, Mr. Iqbal said, "I am honored to have been chosen to lead UBL, one of the most respected and trusted banks in Pakistan. I look forward to working with the talented team at UBL to build on the bank's strong foundation and take it to new heights."

Safe Mix Concrete Limited Releases Quarterly Report for 1st Quarter 2023

Karachi, Safe Mix Concrete Limited has announced the release of its quarterly report for the period ended 2023-03-31. The report provides a detailed analysis of the company's financial performance during the first quarter of the year, including revenue, profits, and operating expenses.

Safe Mix Concrete Limited's revenue for the quarter was PKR 25 million, up from PKR 20 million in the same period last year, representing a 25% increase year-on-year. The company also reported a net profit of PKR 4 million for the quarter, compared to a net loss of PKR 1 million in Q1 2022.

Janana De Malucho Textile Mills Ltd. Recommends Nil Interim Dividend and Bonus Shares

Karachi, Janana De Malucho Textile Mills Ltd. has announced its financial results for the period ended March 31, 2023. The Board of Directors recommended an interim cash dividend of Rs. Nil per share, which is in addition to the interim dividend already paid. The board also recommended the issuance of bonus shares in the proportion of nil shares for every share held, and these shares will be entitled/not entitled to the right shares.

Furthermore, the board recommended the issuance of nil% right shares at par/at a discount/premium of Rs. Nil per share in proportion to nil share(s) for every nil share(s) subject to the consent of the Controller Capital Issues. No other entitlement or corporate action was recommended by the Board of Directors.

The financial report showed that the net sales of the company were Rs. 1,436,632,000 for the quarter ended March 31, 2023, as compared to Rs. 1,817,986,000 for the same period last year. The gross profit was Rs. 12,938,000, compared to Rs. 201,622,000 in 2022. The distribution cost and administrative expenses were Rs. 43,993,000 and Rs. 86,668,000, respectively. The company incurred a finance cost of Rs. 78,044,000 for the period, which led to a loss of Rs. 109,514,000 before taxation. The earnings per share were Rs. (10.93) for the period.

The financial report is available on the company's website, and shareholders can view the details of the recommendations made by the Board of Directors.

Quetta Textile Mills Limited Releases Quarterly Report for 1st Quarter 2023

Karachi, Quetta Textile Mills Limited has released its quarterly report for the period ended March 31, 2023. The report is now available on the company's website for shareholders and investors. The report contains detailed information about the financial performance of the company during the first quarter of 2023. It includes information on the revenue, net profit, earnings per share, and other key financial metrics.

The quarterly report also includes a management discussion and analysis section, where the company's executives provide insights into the company's performance and future plans. This section provides valuable information for shareholders and investors looking to understand the company's strategy and outlook for the future.

Semeen Akhter appointed as CEO of the Company

Karachi, Effective May 1, 2023, Semeen Akhter has been appointed as the new Chief Executive Officer (CEO) of Engro Powergen Qadirpur Limited. She will be replacing Shahab Qadir Khan as the CEO.

The Board of Directors expressed their confidence in Akhter's ability to lead the company forward and drive its growth and development in the years to come.

Pakistan General Insurance Company Limited Transmits Quarterly Report for 1st Quarter 2023

Karachi, The Pakistan General Insurance Company Limited has announced the transmission of its quarterly report for the period ended March 31, 2023. The report is now available for public viewing on the company's website.

The quarterly report provides details on the company's financial performance for the first quarter of 2023. It includes information on the company's revenue, net profit, and other financial metrics, as well as an overview of its operations during the period.